What is the Impact of TKI on Thyroid Function in CML Patients?
NCT07200882 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 76
Last updated 2025-10-01
Summary
Evaluation of the impact of various TKI on thyroid function in patients diagnosed with cml
Conditions
- Leukaemia (Chronic)
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-01
- Primary Completion
- 2027-11-01
- Completion
- 2027-12-01
More Related Trials
-
Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences
NCT05819593 ·Status: NOT_YET_RECRUITING
-
Thyroid Replacement Therapy in Patients With Subclinical Hypothyroidism
NCT04953195 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism
NCT01831869 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer
NCT04868045 ·Status: WITHDRAWN ·Phase: PHASE1
-
Differentiated Thyroid Cancer Patients Treated With Different Doses of Radioactive Iodine.
NCT06134830 ·Status: NOT_YET_RECRUITING
-
TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients
NCT05316922 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of Oxidative Stress and Effect of Levothyroxine Treatment on Oxidative Stress in Hashimoto Disease
NCT01102205 ·Status: COMPLETED
-
Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
NCT00336102 ·Status: COMPLETED
-
Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma
NCT03787303 ·Status: TERMINATED ·Phase: PHASE2
-
Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer
NCT00004062 ·Status: COMPLETED ·Phase: PHASE1
-
The Incidence and Risk Factors of Radiotherapy Induced Hypothyroidism in Head and Neck Cancer With Long Term Follow up
NCT03699098 ·Status: COMPLETED ·Phase: NA
-
The Impact of Subclinical Hypothyroidism on Cardiovascular System
NCT04236232 ·Status: UNKNOWN
-
Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients
NCT05395429 ·Status: UNKNOWN
-
Review of Multimodality Management of Anaplastic Thyroid Cancer
NCT00280852 ·Status: COMPLETED
-
Effect of Levocarnitine Supplementation for the Management of Fatigue in Levothyroxine-Treated Hypothyroid Patients
NCT03372772 ·Status: UNKNOWN ·Phase: NA
-
Metastatic Thyroid Cancer Therapy Optimization With 124I PET Dosimetry
NCT05299437 ·Status: UNKNOWN ·Phase: PHASE2
-
Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases
NCT04411290 ·Status: UNKNOWN
-
Adjuvant Radiotherapy in High Risk Locally Advanced DTC
NCT06558981 ·Status: RECRUITING ·Phase: PHASE3
-
Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism
NCT01848171 ·Status: UNKNOWN ·Phase: PHASE4
-
Can Levothyroxine Treatment Reduce the Development of Cardio-metabolic Disorder in Subclinical Hypothyroidism?
NCT04178928 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma
NCT01707056 ·Status: WITHDRAWN ·Phase: NA
-
Differential Diagnosis and Clinical Treatment Strategies of Thyroid Nodules.
NCT02953288 ·Status: UNKNOWN
-
Thyroxin in Subclinical Hypothyroidism
NCT03712683 ·Status: COMPLETED ·Phase: NA
-
A Prospective Study of Hypothyroidism After Radiotherapy for Breast Cancer
NCT04528225 ·Status: COMPLETED
-
Levothyroxine Treatment in Thyroid Benign Nodular Goiter
NCT00552253 ·Status: COMPLETED ·Phase: NA